Hodgkin's Lymphoma

Hodgkin's lymphoma, also known as Hodgkin's disease, is a type of cancer in the lymphatic system. A rare disease, Hodgkin's lymphoma causes some cells in the lymphatic system to abnormally reproduce, eventually causing tumors to grow and making the body less able to fight infection.

Hodgkin's lymphoma is different from other lymphomas. In most lymphomas, cancer cells make up most of a tumor. In Hodgkin's lymphoma, the cancer cells (usually special cells called Reed-Sternberg cells) only make up a small part of the cells in a cancerous lymph node. The rest of the cells are normal immune cells.

Prognosis

Hodgkin's lymphoma can usually be cured if found and treated early.

Clinical Trials

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.

Before beginning treatment, ask your doctor about any clinical trials you should consider. Learn more about clinical trials for cancer patients.

Clinical trial eligibility flowcharts

Eligibility flowcharts map clinical trials to specific types of cancers to determine if a participant is eligible for the particular clinical trial. View all lymphoma eligibility flowcharts at the Stanford Cancer Institute.

Our Clinic

LYMPHOMA PROGRAM

Receive expert care at a location convenient for you. Make an appointment at our clinic.